Effectiveness Combination of Ginger Extract (Zingiber officinale) and Ranitidine Compared with Combination of  Ranitidine and Placebo against Severity of Functional Dyspepsia by Prapti, Dite Ari et al.
 
Acta Interna The Journal of Internal Medicine, Volume 7 No.1, June 2017: page 47-54 
 
Effectiveness Combination of Ginger Extract (Zingiber officinale) 
and Ranitidine Compared with Combination of  Ranitidine and 
Placebo against Severity of Functional Dyspepsia  
 
Dite Ari Prapti1, Neneng Ratnasari2, Siti Nurdjanah2 
1Specialty Training Program of Internal Medicine, Department of Internal Medicine, 
Faculty of Medicine, Universitas Gadjah Mada, Dr. Sardjito General Hospital  
2Gastroenterohepatology division, Department of Internal Medicine, Faculty of 
Medicine, Universitas Gadjah Mada, Dr. Sardjito General Hospital 
 
ABSTRACT 
Background: Efficacy ranitidine as dyspepsia functional treatment was 8-35 % and 
ginger extracts as a traditional recipe in various countries for generations could be 
used as a therapy dyspepsia, antinausea, spasm, colic, and other stomach complaints. 
Ginger therapeutic effectiveness could reach 68-77% in vivo studies (animal models).  
Objective: To determined how much influence combination of ginger extract and 
ranitidine could improve severity of dyspepsia compared with combination of 
ranitidine and placebo in patients with functional dyspepsia.  
Method: This study was a quasi experimental. The research was conducted from 
December 2015 until April 2016 with 26 participants.  
Results: After getting therapy for 2 weeks in group I, mean SODA score in the pain 
scale decreased (8.4 %) of 29.07 ± 7.29 to 25.08 ± 8.22, statistically significant (p 
<0.046). Mean SODA score in the pain scale group II decreased (7.2%) of  25.38 ± 
6.19 to 24 ± 6.01 (p=0.302). Mean SODA score in the non pain scale in group I 
decreased (7.7%) of 16.84 ± 2.44 to 15.15 ± 2.64 (p=0.074), while in the group II 
decreased (1.6%) of 15.77 ± 2.71 to 15.23 ± 2.94 (p=0.470). Mean SODA score in 
the satisfaction scale in group I increased (19.9%) of 7.77 ± 3.63 to 10.08 ± 3.59 
(p=0.053) while in the group II increased (8.4%) of 9.62 ± 2.72 to 10.92 ± 2.46 
(p=0.072). Comparison decline of SODA score in the pain scale between group I 
was 4.31 ± 6.3 and in group II is 1.23 ± 4.91, greater in group I but not significantly 
(p=0.178) at baseline to week 2nd. Comparison decline of SODA score in the non 
pain scale between group I was 1.69 ± 3.11 and in group II was 0.54 ± 2.6, greater in 
group I but not significantly (p=0.316) at baseline to week 2nd. Comparison 
increasing of SODA score in the satisfaction scale between group I was – 2.31 ± 3.88 
and in group II was -1.31 ± 2.39, greater in group I but not significantly (p=0.437).    
Conclusion: Combination of ginger extract and ranitidine could decrease pain scale, 
non pain scale and increase satisfaction scale more effective clinically than plasebo 
and ranitidine for functional dyspepsia patient, but not statistic significantly  
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Background 
The actual prevalence of 
dyspepsia in the general population 
was unknown, but it estimated 25-
40% of adults had experienced these 
symptoms. According to Indonesian 
Department of Health, ddyspepsia 
ranks 15th of the 50 diseases with the 
highest inpatients hospital. Reports 
outpatient of Sardjito Hospital 
explained that patients who present 
with dyspeptic complaints reached 
40% of cases per year1. Dyspepsia 
patient was quite annoying not to be 
able to perform normal activities2. 
Approximately 50% of patients with 
functional dyspepsia still complained 
of gastrointestinal symptoms during 
follow-up of 5 years even though it 
was normal endoscopic 3.  
One consideration why 
therapy of functional dyspepsia was 
necessary more developed was that the 
long-term use of PPIs could cause side 
effects. Some reports suspected cases 
of PPI induced carcinoma of the 
stomach4. Ranitidine use in the 
community was still relatively high and 
relatively safe 5 and the effectiveness 
of ranitidine for functional dyspepsia 
was only about 8-35% 6, so it needed 
to be combined with other agents. 
Another reason for therapies with 
complementary agents were often 
used by patients for several reasons 
such as ease of use, safer than 
pharmacological agents, the 
perception of their appeal more to use 
natural ingredients rather than drugs6.  
WHO monograph on ginger 
extract based farmakopoia and 
traditional systems of various 
countries used for the treatment of 
dyspepsia, flatulence, spasm, colic, 
vomiting and other stomach 
complaints. Only little published 
research on the effects of ginger 
extract in functional dyspepsia 
patients. 
Methods 
          Method of this study was quasi-
experimental to determine influence 
ginger extract combined with 
ranitidine may improve the severity of 
dyspepsia compared the combination 
of ranitidine and placebo in patients 
with dyspepsia. Research conducted in 
the endoscopy unit, medical record 
unit (medical record installation) and 
outpatient department of internal 
medicine Dr. Sardjito hospital, from 
December 2015 until April 2016. 
Subjects were functional dyspepsia 
patients who had undergone 
endoscopy between January 2013 and 
April 2015 and meet the inclusion and 
exclusion criteria. Demographic data 
were collected in the beginning of 
study. The subjects filled in a SODA 
questionnaire at weeks 0,1, and 2 to 
assess the severity of dyspepsia.  
Inclusion criteria were 
functional dyspepsia patients with ≥ 
18 years of age, meet the ROME III 
criteria and underwent endoscopy, and 
were willing to sign a informed 
consent. Exclution criteria were 
consumed products that contain 
ginger, suffered from organic disease 
or systemic, consumed drugs such as 
anticoagulants (warfarin, heparin) or 
patients with blood clotting disorders 
because it could increase the risk of 
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bleeding, and when using the drug 
salicylates, NSAIDs, glucocorticoids 
because it increased the risk of organic 
dyspepsia and could cause 
overlapping. 
 
Statistical Analysis 
Results were presented as mean ± 
standard deviation. Shapiro-Wilk test 
is to determine if the variable 
distribution was normal or not. 
Variables with normal distribution 
were tested by paired t-test to 
compare SODA scores before and 
after treatment. Independent t-test or 
the Mann Whitney test to compared 
SODA scores in group I (treatment) 
and group II (control). We used the 
Chi Square test or Fisher's exact test 
or the Kolmogorov-Smirnov Z test to 
analyze categorial variables. p <0.05 
regarded as significant7. 
 
Results 
This study was to determine whether 
the extract of ginger combined with 
ranitidine may improve the severity 
dyspepsia compared with placebo 
combined with ranitidine in functional 
dyspepsia patients? Before the main 
research,  questionnaires severity of 
dyspepsia assestment (SODA) were 
validated using    α-Cronbach with the 
results: first reliability of the 
questionnaire of each scale showed the 
pain scale r = 0,917 (good), the non 
pain scale r = 0,809 (good), a 
satisfaction scale r = 0,371 (less), and 
second reliability of each scale shows 
the pain scale r = 0,923 (good), non 
pain scale r = 0,843 (good), and the 
satisfaction scale r = 0,6 (sufficient). 
During January 2013 until May 2015 
there were 198 functional dyspepsia 
patientd who have endoscopy at Dr. 
Sardjito hospital. We gave invitation to 
140 patients and were willing to 
participate in the study as many as 34 
people. Exclusion performed on two 
patients due to anemia, so the overall 
functional dyspepsia patients who met 
the inclusion criteria study was 32 
patients. Group I (ranitidine and 
ginger extract) as many as 18 people, 
and group II (ranitidine and placebo) 
for 14 people. In the course of time 
there were 2 people who did not 
continue the study because of 
persistent pain, and 3 people dropped 
out because of abdominal pain 
advancing. Group II there was 1 
person whose loss of follow-up. A 
total of 26 patients with functional 
dyspepsia were included analysis until 
the end of the study, groups I and II 
respectively 13 people. 
Characteristic data are presented in 
table 1.  
 
Table 1 Characteristic of pasient at baseline 
 
Characteristic  Total (%) 
Sex :  
- Female 11 (42) 
- Male 15 (58) 
Age (year) :  
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- 20 – 30  3 (11) 
- 31- 40   9 (35) 
- More than 40  14 (54) 
Marital status :  
- Married 21 (81) 
- Not married 5  (19) 
Level of education :  
- Primary school 1 (4 ) 
- Secondary school 12 (46) 
- university 13 (50) 
occupation  
- Work at home 11 (42) 
- Goverment employees 6  (23) 
- Others  9  (34) 
 
    Table 2 Comparison characteristic of patients at baseline 
 
Characteristic  Group I 
(n=13) n (%) 
Group II 
(n=13) n (%) 
p value 
95 % CI 
Sex :   0,691* 
- Female 5(38) 6(46)  
- Male 8(62) 7(54)  
Age (year) :   0,570*** 
- 20 – 30  2(15) 1(8)  
- 31- 40   6(46) 3(23)  
- More than 40  5(39) 9(69)  
Marital status :    0,500** 
- Married 10 (77) 11(85)  
- Not married 3(23) 2(15)  
Level of education :    0,584* 
- Primary school 1(8) 0  
- Secondary school 6(46) 6(46)  
- university 6(46) 7(54)  
Occupation:   0,879*** 
- Work at home 7 (54) 4(31)  
- Goverment 
employees 
3(23) 3(23)  
- Others 3(23) 6(46)  
    
 
p < 0,05 regarded as significant, * Chi square test,** Fisher’s exact test,*** 
Kolmogorov-Smirnov Z test 
 
Table 3 Mean SODA score for pain scale and p value for mean changes between I 
(group treatment) and II (group placebo) 
  Baseline Week 1st Week 2nd p 
 I 
 II 
29.07 ± 7.29 
25.38 ± 6.19 
25.61 ± 9.31 
26 ± 7.82 
25.08 ± 8.22 
24 ± 6.01 
0.056* 
 0.572* 
0.658** 
 0.050** 
0.046*** 
 0.302*** 
  
 
 
    Table 4 Mean SODA score for non pain scale and p value for mean changes between 
I (group treatment) and II (group placebo) 
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  Baseline Week 1st Week 2nd p 
 I 
 II 
16.84 ± 2.44 
15.7 ± 2.713 
14.84 ± 3.62 
16.08 ± 3.25 
15.15 ± 2.64 
15.23 ± 2.94 
 
0.069* 
0.527* 
0.711** 
0.217 ** 
0.074*** 
  0.470*** 
   
   
    Table 5 Mean SODA score for satisfacion scale and p value for mean changes 
between I (group treatment) and II (group placebo) 
  Baseline Week 1st Week 2nd p 
 I 
 II 
7.77 ± 3.63  
9.62 ± 2.72  
8.69 ± 2.95  
10.15 ± 3.64 
10.08 ± 3.59 
10.92 ± 2.46  
 
0.381* 
0.464* 
0.053** 
0.352** 
0.053*** 
0.072*** 
 p < 0.05 regarded as significant, paired t test 
  
information :     *     mean baseline-week 1st         ***   mean baseline-week 2nd 
  **    mean week 1st-week 2nd 
 
Table 6 Comparison delta SODA score in the week 0,1,2 between group I and group II 
Scale  Treatment  p value 
Group I Group II 
Pain intensity 
(2-47) 
Baseline  
Change in week  0-1 
Change in week 1-2 
Change in week 0-2 
 
 
29.07 ± 7.29 
3.38 ± 5.92 
0.62 ±  4.17 
4.31  ± 6.3 
 
 
25.38 ± 6.19 
-0.62 ± 3.82 
 2 ± 3.31 
1.23 ± 4.91 
 
 
0.177 
0.052 
0.358 
0.178 
Not pain symptoms 
 (7-35) 
Baseline  
Change in week  0-1 
Change in week 1-2 
Change in week 0-2 
 
 
16.84 ± 2,44 
 2 ± 3,60 
-0.31 ± 2,92 
1.69 ±  3,11 
 
 
15.77 ± 2.71 
-0.31 ±  1.7 
0.85 ±  2.34 
0.54 ± 2.6 
 
 
0.298 
0.048 
0.278 
0.316 
Satisfaction  (2-23) 
Baseline  
Change in week  0-1 
Change in week 1-2 
Change in week 0-2 
 
 7.77 ±  3.63 
-0.92 ± 3.662 
 -1.38 ± 2.32 
-1.23 ± 4.26 
 
9.62 ± 2.72 
-0.54 ± 2.57 
-0.85 ± 2.88 
-1.31 ± 2.39 
 
0.156 
0.759 
  0.448* 
0.955 
 p < 0,05 regarded as significant, unpaired  t-test, * Mann-Whitney test 
 
Discussion 
             This study showed the 
addition of ginger extract in the 
treatment group reduced mean of pain 
scale SODA scores and this significant 
reduction obtained after receiving 
ginger extract for 2 weeks. In table 2 
above, we could see a decrease in 
mean of pain scale SODA score of 
29.07 ± 7.29 to 25.08 ± 8.22 in the 
second week and this reduction was 
significant (p = 0.046), while the 
decline in 1st week was not significant 
(p = 0.056). In the control group there 
is also a decrease in pain scale SODA 
score, but the decline was not 
significant (p = 0.302). The mean of 
non pain scale SODA score in giving 
ginger extract for 2 weeks decreased 
greater symptoms (7.7%) compared 
with placebo (1.6%) but a decrease in 
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the symptoms were not significant (p 
= 0.074 ).  
The results were matching 
with research Drozdov about the 
effect of ginger (treatment) or 
diclofenac sodium (positive control) to 
gastrointestinal health in the 
population, which showed a 
significant slight decrease in pain scale 
SODA score, but there was no change 
in the  non pain scale SODA score in 
the ginger group8. This study also 
showed that the levels of 
prostaglandin (PG) gastric mucosa in 
the group receiving ginger extract 
showed elevated levels of PGE1, 
PGE2, PGF2α and  gastrin-17 serum 
(stimulator PG) compared to the 
control group which was increasing 
the potential protective mucous. 
The declines in mean pain 
scale SODA score were statistically 
significant after 2 weeks of ginger 
extract. This was consistent with 
Attilio research who received efficacy 
short-term treatment of functional 
dyspepsia with supplementation of 
ginger extract and artichoke9. The 
effect was statistically significant 
compared to placebo. Treatment 
efficacy appears when day 14 th. The 
treatment group demonstrated the 
efficacy of therapy in 86.2% of cases 
after receiving supplementation for 28 
days. 
 The addition of ginger extract 
in this treatment group was different 
from Attilio research which the 
addition did not have a significant 
effect9. In Table 10 showed that after 
two weeks treatment the mean 
difference in pain score decrease 
SODA scale higher in the treatment 
group compared with the control 
group (4.31 ± 6.3 vs. 1.23 ± 4.91), 
although this difference was 
statistically not significant (p = 0.178). 
The mean difference in reduction non 
pain scale SODA score higher in the 
treatment group compared with the 
control group (1.69 ± 3.11 vs. 0.54 ± 
2.6), also not statistically significant (p 
= 0.316). This may be due to relatively 
small sample size and treatment time 
was not long enough, and cannot be 
ascertained whether the patient 
actually already taking capsules as 
instructed. Results in table 5 shows 
that the group I, addition ginger 
extract after two weeks, the level of 
satisfaction with the health-related 
dyspepsia were higher percentage 
(19.9%) compared with the placebo 
group (8.4%) despite the increasing in 
satisfaction was not statistically 
significant in both groups. The higher 
increasing delta SODA score for 
satisfaction also could be seen in table 
6 where in the group I, the satisfaction 
scale changes in the second week 
compared to baseline was -2.31 ± 
3.88, while the second group -1.31 ± 
2.39 ( p = 0.437). Satisfaction scale 
SODA questionnaire of this language 
when translated into Indonesian 
results were difficult to understand by 
the respondent, and the results of the 
validation analysis of questionnaire 
results α-Cronbach  r = 0.6 (sufficient) 
that might affect the  significantly 
results. Nunnally recommended a 
minimum standard level of reliability 
was 0.7 for the group. Lately alpha 0.8 
ten cited as the minimum10. 
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              Limitations of this study were 
not controlled for confounding factors 
such as dietary intake, lifestyle and 
psychosocial factors. The absence of 
evaluation of the treatment was given 
by the supervisor, with a record time 
of drug administration schedule and 
records the rest of medicine. The 
process of translating the 
questionnaire SODA at the time of 
validation was not up to standard. 
Ideally the questionnaire translated 2 
times by linguists (2 different 
translators) from an officionale 
institution (eg, Language Training 
Center), and then sent back to the 
Department of Veterans Affairs 
Health Services Research and 
Development Field Program, the 
agency that compiled the 
questionnaire SODA, for rated is 
already in line with the original 
questionnaire. Another limitation was 
the lack of power research, for each 
scale was about 37.94 %, 25.66 %, and 
19.1 %, indicating that the study did 
not have sufficient power to prove the 
differences were obtained significant 
statistically, due to the sample size 
calculation was based only one the 
scale and time for follow-up study was 
less long. To reached power about 80 
%, sample had to added be 129 
samples for every group. 
Conclutions 
             The combination of ginger 
extract and ranitidine could decrease 
pain scale, non pain scale and 
increased satisfaction with the health-
related scale of SODA score more 
effective clinically than the 
combination of ranitidine and placebo 
in patients with functional dyspepsia, 
but was not statistically significant. 
References 
1. Dwijayanti, H., Ratnasari, N., dan 
Susetyowati, 2008. Asupan 
Natrium dan Kalium 
Berhubungan dengan Frekuensi 
Gejala Sindrom Dispepsia 
Fungsional. Jurnal Gizi Klinik 
Indonesia ; 5 (1) : 36-40. 
2. Talley, N.J., Weaver, A.L., 
Zinsmeister, A.R., 1995. Impact 
of Functional Dyspepsia on 
Quality of Life. Dig Dis Sci ; 40 : 
584-9 
3. Lacy, B.E., Weiser, K.T., 
Kennedy, A.T.,Crowell,M.D., 
Talley,N.J., 2013. Functional 
Dyspepsia : The Economic 
Impact to Patients. Aliment 
Pharmacol Ther. doi : 
10.1111/apt.12355. 
4. Waldum , H.L., Gustafsson, B., 
Fossmark,R.,  Qvigstad,G.,2005. 
Antiulcer Drugs and Gastric 
Cancer. Digestive Diseases and 
Sciences; 50( 1) :  S39–S44. 
5. Sabesin S.M.,1993. Safety Issues 
Relating to Long-Term Treatment 
with Histamine H2-Receptor 
Antagonist. Aliment Pharmacol 
Ther ; 7(2): 35-40. 
6. Lacy, B.E., Talley,N.J., Locke, 
G.R., Bouras, E.P., DiBaiser, 
J.K.,El-Serag, H.B.,Abraham, 
B.P.,2012. Review Article : 
Current Treatment Options and 
Management of Functional 
Dyspepsia. Aliment Pharmacol 
Ther;36 : 3-15. 
 
Acta Interna The Journal of Internal Medicine, Volume 7 No.1, June 2017: page 47-54 
 
 
 
7. Dahlan, S.M, 2011. Statistik  
Untuk Kedokteran dan Kesehatan. 
Salemba Medika. 
8. Drozdov, V.N., Kim V.A., 
Tkachenko E.V., Varvanina., 
2012. Influence of a Specific 
Ginger Combination on 
Gastropathy Conditions in 
Patients with Osteoarthritis of the 
Knee or Hip. The Journal of 
Alternatif and Complementary 
Medicine; 18(6):583-88. 
9. Attilio,G., Davide, Mario, 2015. 
The Effect of Ginger and 
Artichoke Extract 
Supplementation  on Functional 
Dyspepsia : A Randomised, 
Double-Blind, and Placebo-
Controlled Clinical Trial. Evidence-
Based Complementary and Alternative 
Medicine ;  article ID 915087. 
Hindawi Publishing Corporation 
10. Nunnally, J. C., 1978. 
Psychometric theory (2nd ed.). 
New York: McGraw-Hill. 
